Business
PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses Thereof
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc.  ...
About this update from Preveceutical Medical Inc
[{"type":"text","content":"PreveCeutical - International Filing of Thermoresponsive Sol-Gels Containing Cannabinoids & Uses ThereofVancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the \"Company\" or \"PreveCeutical\"), is pleased to announce that PreveCeutical is furthering the progress of its Sol-Gel Cannabinoid Therapies patent family based on International Patent Application PCT/IB2021/022211 (Thermoresponsive Sol-Gels containing cannabinoids), and is taking the International patent application forward in the US, Europe, Canada and Australia.The US patent application (USSN 18/043398) has been filed with amended claims, together with its Australian and Canadian counterparts, and the European application is being filed before the deadline of 31 March 2023. PreveCeutical is prosecuting the patent applications to maximize the scope of protection available in those countries and to ensure that effective and secure patents are obtained as we continue our clinical process. PreveCeutical's Chief Executive Officer, Mr. Stephen Van Deventer, commented, \"We are ensuring that the Cannabinoid Sol-Gel therapies are well protected Internationally. PreveCeutical is prosecuting the patent applications to maximize the scope of protection available in those countries and to ensure that effective and secure patents are obtained as we continue our clinical process\".Although PreveCeutical believes that any such intentions, plans, estimates, beliefs, and expectations in this news release are reasonable, there can be no assurance that any such intentions, plans, beliefs, and expectations will prove to be accurate or successful.About PreveCeuticalPreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. The Company aims to be a leader in the preventive health sciences sector. With the completion of three of its research programs, the Company is actively working on the development, clinical trials, and commercialization of its products; and has filed a number of provisional patent applications to protect the intellectual property from its research programs.For more information about PreveCeutical, please visit our website, www.PreveCeutical.com or follow us on Twitter and Facebook. O...